Viewing Study NCT06089018



Ignite Creation Date: 2024-05-06 @ 7:39 PM
Last Modification Date: 2024-10-26 @ 3:11 PM
Study NCT ID: NCT06089018
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2023-10-18
First Post: 2023-10-12

Brief Title: Observational Study of Digital Biomarkers of Myotonia and Gait in Adults and Children With Myotonic Dystrophy
Sponsor: Stanford University
Organization: Stanford University

Study Overview

Official Title: Observational Study of Digital Biomarkers of Myotonia and Gait in Adults and Children With Myotonic Dystrophy
Status: ACTIVE_NOT_RECRUITING
Status Verified Date: 2023-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this observational study is to assess movement in individuals with Myotonic Dystrophy Type 1 DM1 and Type 2 DM2 using digital biomarker tools The long-term aim of this study is to incorporate these outcomes into clinical trials of DM1 and DM2 therapies Participants will complete a series of assessments that allow for researchers to measure hand myotonia and walking quality including a Video Hand Opening Test VHOT grip strength 10 meter walkrun test 6 minute walk test Timed Up and Go TUG Motor Function Measures-32 MFM-32 test and more These assessments may be recorded to detect and map participants motion and walking patterns Several patient reported outcome PROs questionnaires will also be recorded Participants may also be asked to monitor exercise and sleep activity at home using an Actigraph wearable device This study is divided into 2 parts Part A consists of a single visit Part B consists of a 1-year longitudinal study with 3 clinical follow-up visits
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None